Related Experiment Video
Updated: Jul 12, 2025

Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions
Published on: July 22, 2022
RNA interference-mediated hookworm control by gut-dwelling lactic acid bacteria
Shaziya Bi1, Manisha Sabnis1,2, Anamika Singh1,2
1AbGenics LifeSciences Pvt Ltd., Venture Center, Pune, Maharashtra, India.
This study introduces a novel probiotic therapy using engineered Lactococcus lactis to deliver RNA interference (RNAi) targeting hookworm enzymes. This approach effectively reduces parasite infection and organ damage in mouse models, offering a sustainable solution for geohelminth control.
Area of Science:
- Parasitology
- Molecular Biology
- Probiotics
- RNA Interference (RNAi)
Background:
- Geohelminth infections pose challenges due to complex life cycles and resistance to traditional anthelmintics.
- Hookworm infections (Ancylostoma sp. and Necator sp.) are significant global health issues requiring novel therapeutic strategies.
- Existing treatments are becoming less effective, necessitating the development of sustainable parasite management solutions.
Purpose of the Study:
- To develop a novel probiotic-based therapy utilizing RNA interference (RNAi) against essential hookworm enzymes.
- To engineer Lactococcus lactis to produce and deliver double-stranded RNA (dsRNA) targeting astacin-like metalloprotease (Ac-MTP-1) in Ancylostoma sp.
- To evaluate the efficacy of this engineered probiotic in controlling hookworm infection and associated pathology.
Main Methods:
- Genetic engineering of Lactococcus lactis to produce dsRNA targeting the hookworm enzyme Ac-MTP-1.
- Development of a gut delivery RNAi vector for oral administration of engineered probiotics.
- In vivo testing in mouse models to assess the impact of engineered probiotics on hookworm infection and organ damage.
Main Results:
- Engineered probiotics successfully delivered dsRNA, leading to RNAi-mediated knockdown of the target enzyme in hookworms.
- A 70% reduction in larval penetration of the gut lining and a 50% decrease in migration to vital organs were observed.
- Significant reversal of liver (30%-40%) and kidney (50%-60%) damage in mouse models pre-treated with engineered L. lactis.
Conclusions:
- This study demonstrates the first successful oral administration of genetically engineered probiotics for RNAi-based gene knockdown in hookworms.
- The novel 'RNAi food' approach shows potential for interrupting the hookworm life cycle and managing infections.
- This strategy can complement existing anthelmintics and be extended to other hookworm species like A. duodenalis and A. ceylanicum.
More Related Videos
09:47Selective Cleaning of Wild Caenorhabditis Nematodes to Enrich for Intestinal Microbiome Bacteria
Published on: August 13, 2021
06:56Preparing and Rearing Axenic Insects with Tissue Cultured Seedlings for Host-Gut Microbiota Interaction Studies of the Leaf Beetle
Published on: October 8, 2021